Učitavanje...
Impact of immunotherapy use in patients with stage IV pancreatic carcinoma
BACKGROUND: Most patients with pancreatic cancer have non-resectable disease at the time of diagnosis and usually die within 6–12 months. Despite indications in other solid tumors, the role of immunotherapy (IO) is unknown for late stage, advanced pancreatic cancer. METHODS: Using the National Cance...
Spremljeno u:
| Izdano u: | J Gastrointest Oncol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7475322/ https://ncbi.nlm.nih.gov/pubmed/32953149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-191 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|